European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
Inflammatory Bowel Disease (IBD)
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
PDF) P621 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study
WINTER
PDF) Oral azathioprine for steroid refractory severe ulcerative colitis | Gerassimos Mantzaris - Academia.edu
Julien KIRCHGESNER | Professor (Associate) | MD, PhD | Hôpital Saint-Antoine (Hôpitaux Universitaires Est Parisien), Paris | Service d'Hépato-Gastro-Entérologie - Nutrition
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Palle BAGER | Clinical Nurse Specialist / Senior researcher / Associate Professor at Aarhus University | RN, MPH, PhD | Aarhus University Hospital, Århus | AUH | Department of Hepatology and Gastroenterology
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Orally Administered Platinum Nanomarkers for Urinary Monitoring of Inflammatory Bowel Disease | ACS Nano
ECCO in Vienna was the Best Congress Ever!
ECCO in Vienna was the Best Congress Ever!
PDF) The histopathological approach to inflammatory bowel disease: A practice guide
s of ECCO
PDF) Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Untitled
iBDNEWS#1/14
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Resul
